Diffuse Large B-Cell Lymphoma

REMoDL-B

A randomised evaluation of molecular guided therapy for Diffuse Large B-Cell Lymphoma with Borteziomib

SADAL

b Open-label, Randomized Two-arm Study of

Selinexor (KPT-330) with Low Dose Dexamethasone in Patients with Relapsed /

Refractory Diffuse Large B-Cell Lymphoma(DLBCL)

 

A Phase 2